and 0.1% pyridine in CH2Cl2) to give the product 12 as a white
foam (663 mg, 80%): Rf 0.15 (7.5% CH3OH in ethyl acetate). 1H
NMR (300 MHz, DMSO-d6) d 11.32 (br s, 1H, NH), 11.12 (br s,
1H, NH), 7.81 (d, 1H, J = 1.2 Hz, H-6), 7.40–6.94 (m, 14H, Ph,
H-6), 6.00 (dd, 1H, J = 6.6, 7.2 Hz, H-1¢), 5.08 (d, 1H, J = 4.5 Hz,
OH), 3.76 (m, 1H, H-3¢), 3.63 (t, 1H, J = 3.6 Hz, H-4¢), 3.50–3.15
(m, 3H, H-5¢, H-7¢), 2.05–1.90 (m, 2H, H-2¢), 1.78 (s, 3H, CH3),
1.72 (d, 3H, J = 1.2 Hz, CH3), 1.40–1.25 (m, 2H, H-6¢); 13C NMR
(75 MHz, DMSO-d6) d 164.2 (C-4), 163.73 (C-4), 150.9, 150.7,
150.5, 150.3, 148.0 (C-2, Ph), 137.7, 135.6, 131.2, 131.1, 129.8,
129.7, 127.7, 127.0, 126.8, 123.4, 123.2, 123.1, 122.5, 116.3, 115.9
(C-6, Ph), 109.7, 108.5 (C-5), 86.5, 83.1, 76.2, 71.1, 70.3 (C-1¢,
C-3¢, C-4¢, C-5¢, CPh3), 54.9 (C-7¢), 43.5 (C-2¢), 30.8 (C-6¢), 12.3
(CH3), 11.9 (CH3). HiRes ESI MS m/z (M + Na+) found/calc.
673.2269/673.2274.
buffer, 38 min; 70–100% buffer, 7 min; 100% buffer, 10 min.
All fractions containing 5¢-O-DMT protected oligonucleotide
(retention time 20–30 minutes) were collected and concentrated.
The products were detritylated by treatment with an 80% aqueous
solution of acetic acid for 20 min, and finally isolated by
precipitation with ethanol at -18 ◦C overnight. MALDI-MS m/z
(found/calcd); ON3 (3979.1/3982.6), ON4 (3532.3/3533.4), ON5
(3530.2/3533.4), ON6 (3682.4/3685.4), ON7 (3442.8/3444.3),
ON8 (3444.3/3444.3), ON9 (3594.4/3596.3). After dissolution
in double distilled water, the concentrations were determined
spectrometrically at 260 nm in the pH 7.0 buffer, assuming an
extinction coefficient for the modified double-headed nucleoside
of equal to twice that of thymidine. The UV-melting curves were
acquired at 260 nm with a scan rate of 0.2 ◦C min-1 cycled between
15 and 75 ◦C after denaturation at 80 ◦C. All melting curves were
found to be reversible. The melting temperatures were taken as
the first derivatives of the absorbance versus temperature up-curve
and reported as the average of two measurements.
Preparation of 5¢(S)-C-(2-(thymin-1-yl)ethyl)-5¢-O-
(9-phenylxanthen-9-yl)-3¢-O-(P-b-cyanoethoxy-N,N -
diisopropylaminophosphinyl)thymidine (13)
Modelling experiment
A solution of compound 12 (500 mg, 0.923 mmol) and diiso-
propylammonium tetrazolide (236 mg, 1.39 mmol) in anhydrous
DMF (10 mL) and anhydrous CH3CN (10 mL) was stirred at
room temperature and N,N,N ¢,N¢-tetraisopropylphosphoramidite
(0.44 mL, 1.38 mmol) was added. The reaction mixture was stirred
for 10 h and diluted with ethyl acetate (20 mL). The solution
was washed with brine (2 ¥ 20 mL). The combined aqueous
phase was extracted with ethyl acetate (20 mL), and the combined
organic phase was dried (Na2SO4) and concentrated under reduced
pressure. The residue was purified by column chromatography (1–
6% CH3OH and 0.1% pyridine in CH2Cl2) to give the product 13
as a white foam (291 mg, 45%): Rf 0.25 (7.5% CH3OH in ethyl
acetate). 31P NMR (121.5 MHz, CDCl3) d 150.26, 149.88. HiRes
ESI MS m/z (M + Na+) found/calc. 873.3347/873.3353.
The MD-simulations in Fig. 2b were obtained by the same
protocol as used in ref. 8.
Acknowledgements
The Danish National Research Foundation, The Danish Research
Agency and Møllerens Fond are thanked for financial support.
Mrs Birthe Haack is thanked for technical assistance.
References and Notes
1 H. Yan, Science, 2004, 306, 2048.
2 J. Wengel, Org. Biomol. Chem., 2004, 2, 277.
3 P. Mouritzen, A. Toftgaard Nielsen, H. M. Pfundheller, Y. Choleva, L.
Kongsbak and S. Møller, Expert Rev. Mol. Diagn., 2003, 3, 89.
4 J. Kurreck, Eur. J. Biochem., 2003, 270, 1628.
5 T. Wu, M. Froeyen, G. Schepers, K. Mullens, J. Rozenski, R. Busson,
A. Van Aerscot and P. Herdewijn, Org. Lett., 2004, 6, 51.
6 S. L. Pedersen and P. Nielsen, Org. Biomol. Chem., 2005, 3, 3570.
7 T. Wu, K. Nauwelaerts, A. Van Aerschot, M. Froeyen, E. Lescrinier
and P. Herdewijn, J. Org. Chem., 2006, 71, 5423.
8 M. S. Christensen, C. M. Madsen and P. Nielsen, Org. Biomol. Chem.,
2007, 5, 1586.
9 M. S. Christensen, A. D. Bond and P. Nielsen, Org. Biomol. Chem.,
2008, 6, 81.
10 N. B. Leontis, W. Kwok and J. S. Newman, Nucleic Acids Res., 1991,
19, 759.
11 H. B. Lazrek, H. Kha¨ıder, A. Rachdi, J.-L. Barascut and J.-L. Imbach,
Tetrahedron Lett., 1996, 37, 4701.
12 S. Guaillarme, S. Legoupy, A.-M. Aubertin, C. Olicard, N. Bour-
gougnon and F. Huet, Tetrahedron, 2003, 59, 2177.
13 J.-M. Xu, C. Qian, B.-K. Liu, Q. Wu and X.-F. Lin, Tetrahedron, 2007,
63, 986.
14 A. M. Sørensen, K. E. Nielsen, B. Vogg, J. P. Jacobsen and P. Nielsen,
Tetrahedron, 2001, 57, 10191.
Oligonucleotide synthesis and hybridisation experiments
The oligodeoxynucleotides were synthesised using an automated
Expedite 8909 nucleic acid synthesis system following the phos-
phoramidite approach. Synthesis of oligonucleotides ON3–ON9
was performed on a 0.2 mmol scale by using 2-cyanoethyl phos-
phoramidites of standard 2¢-deoxynucleosides in combination
with the modified phosphoramidite 13. The synthesis followed
the regular protocol employing standard CPG supports and 4,5-
dicyanoimidazole as the activator except in the case of the modified
amidites, which were manually coupled using 0.05 M amidite and
0.5 M tetrazole as the activator in CH3CN for 20 min. The coupling
yields for 13 in combination with the following unmodified
amidites were in the range of 91–100%. The 5¢-O-DMT oligonu-
cleotides were removed from the solid support by treatment with
concentrated aqueous ammonia at 55 ◦C for 16–24 h, which also
removed the protecting groups. The oligonucleotides were purified
by reversed-phase HPLC on a Waters 600 system using an Xterra
prep MS C18; 10 mm; 7.8 ¥ 150 mm column; gradient of buffer
(0.05M triethylammonium acetate) in 75% CH3CN(aq): 0–70%
15 P. K. Sharma, B. H. Mikkelsen, M. S. Christensen, K. E. Nielsen,
C. Kirchhoff, S. L. Pedersen, A. M. Sørensen, K. Østergaard and P.
Nielsen, Org. Biomol. Chem., 2006, 4, 2433.
16 V. Banuls and J.-M. Escudier, Tetrahedron, 1999, 55, 5831.
17 H. Trafelet, E. Stulz and C. Leumann, Helv. Chim. Acta, 2001, 84, 87.
3988 | Org. Biomol. Chem., 2008, 6, 3983–3988
This journal is
The Royal Society of Chemistry 2008
©